DekaBank Deutsche Girozentrale
ECYT

DekaBank Deutsche Girozentrale’s Endocyte, Inc. Common Stock ECYT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-21,200
Closed -$85K – 1122
2015
Q4 		$85K Hold
21,200
– – ﹤0.01% 982
2015
Q3 		$97K Buy
21,200
+1,000
+5% +$5.23K ﹤0.01% 970
2015
Q2 		$105K Buy
20,200
+500
+3% +$3K ﹤0.01% 1005
2015
Q1 		$123K Sell
19,700
-2,500
-11% -$14.4K ﹤0.01% 972
2014
Q4 		$139K Sell
22,200
-2,000
-8% -$12.2K ﹤0.01% 899
2014
Q3 		$147K Buy
24,200
+500
+2% +$3.42K ﹤0.01% 857
2014
Q2 		$156K Buy
23,700
+1,500
+7% +$16.9K ﹤0.01% 784
2014
Q1 		$529K Buy
22,200
+1,500
+7% +$21.8K 0.01% 568
2013
Q4 		$220K Buy
20,700
+600
+3% +$6.63K ﹤0.01% 657
2013
Q3 		$268K Buy
+20,100
New +$318K ﹤0.01% 621

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ECYT Position: Q1 2016 in Review

DekaBank Deutsche Girozentrale sold out of Endocyte, Inc. Common Stock (ECYT) in Q1 2016, closing a stake of 21,200 shares — an estimated $85K sold.

DekaBank Deutsche Girozentrale first reported a position in ECYT in Q3 2013 and held it in 10 quarters. The position peaked at $529K in Q1 2014. 97 funds tracked by Wall St. Rank hold ECYT as of Q1 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Endocyte, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 21,200 Endocyte, Inc. Common Stock shares in Q1 2016, an estimated $85K.
  • DekaBank Deutsche Girozentrale first reported a position in Endocyte, Inc. Common Stock in Q3 2013 and held it in 10 quarters.
  • DekaBank Deutsche Girozentrale's Endocyte, Inc. Common Stock position peaked at $529K in Q1 2014.
  • 97 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2016, filed 13 May 2016.